Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Reducing opioid misuse among adolescents through physician education.

Arora NS, Marcotte KM, Hopper JA.

Subst Abus. 2018 Jan 2;39(1):6-8. doi: 10.1080/08897077.2017.1356788. Epub 2017 Sep 1.

PMID:
28723248
2.

Implementing the Collaborative Care Model as Part of a Countywide Initiative.

Valenstein M, Dalack GW, Simoncic T, Metzger K, Deneke DE, Richardson CR, Hopper JA, Rion R, Williams BC, Miller A, Ryan P, Cuson S, McLaughlin M, Spangler K, LePlatte-Ogini D, Baum N, Rheingans C, Udow-Phillips M.

Psychiatr Serv. 2016 May 1;67(5):476-8. doi: 10.1176/appi.ps.201600029. Epub 2016 Feb 29.

PMID:
26927581
3.

Designer drugs 2015: assessment and management.

Weaver MF, Hopper JA, Gunderson EW.

Addict Sci Clin Pract. 2015 Mar 25;10:8. doi: 10.1186/s13722-015-0024-7.

4.

Isolated shoulder weakness as a result of a cortical infarction in the precentral gyrus.

Entezami P, Hopper JA.

J Community Hosp Intern Med Perspect. 2015 Apr 1;5(2):26220. doi: 10.3402/jchimp.v5.26220. eCollection 2015.

5.

A multifactorial intervention for hospital opioid management.

Akce M, Suneja A, Genord C, Singal B, Hopper JA.

J Opioid Manag. 2014 Sep-Oct;10(5):337-44. doi: 10.5055/jom.2014.0223.

PMID:
25350475
6.

A randomized trial of computer-delivered brief intervention and low-intensity contingency management for smoking during pregnancy.

Ondersma SJ, Svikis DS, Lam PK, Connors-Burge VS, Ledgerwood DM, Hopper JA.

Nicotine Tob Res. 2012 Mar;14(3):351-60. doi: 10.1093/ntr/ntr221. Epub 2011 Dec 9.

7.

The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.

Duncan MJ, Hester JM, Hopper JA, Franklin KM.

Eur J Neurosci. 2010 May;31(9):1646-54. doi: 10.1111/j.1460-9568.2010.07186.x.

8.

Bariatric surgery history among substance abuse treatment patients: prevalence and associated features.

Saules KK, Wiedemann A, Ivezaj V, Hopper JA, Foster-Hartsfield J, Schwarz D.

Surg Obes Relat Dis. 2010 Nov-Dec;6(6):615-21. doi: 10.1016/j.soard.2009.12.008. Epub 2010 Jan 20.

PMID:
20207591
9.

A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence.

Hopper JA, Wu J, Martus W, Pierre JD.

J Opioid Manag. 2005 Mar-Apr;1(1):31-5.

PMID:
17315409
10.

Prescription drug use and abuse. Risk factors, red flags, and prevention strategies.

Isaacson JH, Hopper JA, Alford DP, Parran T.

Postgrad Med. 2005 Jul;118(1):19-26. Review.

PMID:
16106916
11.

Injection drug use and wound care.

Pieper B, Hopper JA.

Nurs Clin North Am. 2005 Jun;40(2):349-63. Review.

PMID:
15924899
12.

Tobacco cessation: new challenges, new opportunities.

Hopper JA, Gallagher RE.

J Cancer Educ. 2003 Fall;18(3):128-33.

PMID:
14512260
13.

Management of the hospitalized injection drug user.

Hopper JA, Shafi T.

Infect Dis Clin North Am. 2002 Sep;16(3):571-87. Review.

PMID:
12371116
14.

Injection drug use in North America.

Schoener EP, Hopper JA, Pierre JD.

Infect Dis Clin North Am. 2002 Sep;16(3):535-51, vii. Review.

PMID:
12371114
15.

Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans.

Greenwald MK, Schuh KJ, Hopper JA, Schuster CR, Johanson CE.

Psychopharmacology (Berl). 2002 Apr;160(4):344-52. Epub 2002 Jan 31.

PMID:
11919661
16.

Environmental tobacco smoke exposure among urban children.

Hopper JA, Craig KA.

Pediatrics. 2000 Oct;106(4):E47.

PMID:
11015542
17.

Abuse liability assessment of sibutramine, a novel weight control agent.

Schuh LM, Schuster CR, Hopper JA, Mendel CM.

Psychopharmacology (Berl). 2000 Jan;147(4):339-46.

PMID:
10672626
18.
19.
20.

Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures.

Cohen GH, Hopper JA, Goldstein AL.

Ann N Y Acad Sci. 1975 Feb 28;249:145-53.

PMID:
165764

Supplemental Content

Loading ...
Support Center